Analysis

Xvivo Perfusion Ab (XVIVO) Stock Analysis

Xvivo Perfusion Ab investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to XVIVO.

websiteXVIVO/analysis/XVIVO

Xvivo Perfusion Ab

Xvivo Perfusion Ab investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to XVIVO.

Stock profile

Ticker

XVIVO

Asset type

Stock

Market cap

$828.2M

Sector

Health Technology

Industry

Medical Specialties

Currency

SEK

Ticker listings

Xvivo Perfusion Ab may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • XVIVO primary listing
  • 0RKL
  • XVIPF
  • A1J5GZ
  • 3XV
  • XVIVOS
  • XVIPY

Latest Xvivo Perfusion Ab news

Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation

TORONTO, April 22, 2026--XVIVO, a global medtech company in the organ transplant industry, today announced late-breaking preliminary data from the PRESERVE Trial (NCT05881278) e...

The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal

GOTHENBURG, SE / ACCESS Newswire / April 16, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - At last year's ISHLT congress, in April 2025, the one-year results from t...

Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)

GOTHENBURG, SE / ACCESS Newswire / March 19, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - (the "Company"), reg. no. 556561-0424, with its registered office in Möln...

CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members

This corrects and replaces a release that posted earlier today. GOTHENBURG, SE / ACCESS Newswire / February 20, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Correc...

The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors

GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Ahead of the Annual General Meeting to be held on 27 April 2026, the...

Research sections

Valuation

Review valuation context for Xvivo Perfusion Ab.

Future growth

Review future growth context for Xvivo Perfusion Ab.

Past performance

Review past performance context for Xvivo Perfusion Ab.

Financial health

Review financial health context for Xvivo Perfusion Ab.

Dividend

Review dividend context for Xvivo Perfusion Ab.

Management

Review management context for Xvivo Perfusion Ab.

Ownership

Review ownership context for Xvivo Perfusion Ab.

Other information

Review other information context for Xvivo Perfusion Ab.

Community

Review community context for Xvivo Perfusion Ab.